Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Apimeds Pharmaceuticals US, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Erick Frim, Chief Financial Officer (Form 8-K filed 2026-10-01). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Inscobee Inc. (filed 2026-05-07).
Who is behind it
Apimeds Pharmaceuticals US, Inc.: incorporated in Delaware; business address in Matawan, New Jersey; industry Pharmaceutical Preparations (Form D, 2026-10-01).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-05-07 | Inscobee Inc. | 34.3% |
| Schedule 13D/A, 2026-03-30 | Inscobee Inc. | 34.3% |
| Schedule 13D/A, 2026-03-20 | Inscobee Inc. | 34.3% |
| Schedule 13G, 2026-02-11 | Ayrton Capital LLC | 9.99% |
| Schedule 13D/A, 2026-01-26 | Inscobee Inc. | 34.3% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-10-01 | Erick Frim | Chief Financial Officer | departed | |
| Form 8-K, 2026-10-01 | Eric Sherb | Chief Financial Officer | appointed | 2026-10-01 |
| Form 8-K, 2026-10-01 | Eric Sherb | appointed | ||
| Form 8-K, 2026-05-05 | Sungjoon Chae | Chief Executive Officer | appointed |
Money raised
Latest IPO step: Apimeds Pharmaceuticals US, Inc. filed its final IPO prospectus, ticker APUS (424B4, 2025-05-09).
IPO filings: 424B4, 2025-05-09, S-1/A, 2025-02-10, S-1/A, 2025-02-06, S-1/A, 2025-01-29, S-1/A, 2025-01-10; ticker APUS on NYSE American.
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-02-17); completed an acquisition (2025-12-02).
Related pages
Leadership changes5%+ holdersIPO filings
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/apimeds-pharmaceuticals-us